Latest News
Latest News
Comments open for U.K.’s transgender care guideline
The guideline aims to address the specific needs of transgender and gender-diverse individuals that, according to the guideline, are currently not...
From the Journals
Is Lp(a) a marker for aortic calcium onset?
A link between elevated lipoprotein(a) and new-onset aortic valve calcification is found, but not necessarily calcium progression.
From the Journals
Ongoing debate whether COVID links to new diabetes in kids
The current study may have been underpowered and too small to show a significant association between COVID-19 and new diabetes.
Latest News
Routine weight counseling urged for women at midlife
“Midlife women gain weight at an average of approximately 1.5 pounds per year, which increases their risk for transitioning from normal or...
From the Journals
Ezetimibe plus statin: Attractive bypass to high-dose monotherapy
Early initiation of this approach should be considered in patients with challenging lipid disorders who are at increased risk of atherosclerotic...
From the Journals
Detransitioners lament inadequate clinical support
Transgender individuals who stop medical transitions avoid therapists and doctors, fearing stigma, a new study finds.
From the Journals
For patients with peripheral artery disease, pain can be gain
Walking, especially when their legs hurt, made a significant positive difference for people with peripheral artery disease.
From the Journals
Remnant cholesterol captures residual CV risk in patients with T2D
Baseline and follow-up remnant cholesterol levels predict cardiovascular events in patients with type 2 diabetes.
From the Journals
Alcohol-related cirrhosis associated with higher risk of fractures, death
The higher risk of fractures remained elevated for the first two decades after diagnosis.
Conference Coverage
Vitamin D supplements do not lower risk of fractures
“I would use markers of bone formation as a better measure to determine whether they need vitamin D or not, specifically looking at parathyroid...
From the Journals
Medicare advantage tied to less use of pricey diabetes drugs
“We worry that the cost-containment challenges [associated with MA plans] may be limiting use of these newer treatments.”